Clinical Trial Update: Study of IBI363 in Patients with Advanced First-line Gastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating IBI363 in combination with chemotherapy for first-line advanced gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• IBI363

Snippet

Sponsor: Xiangdong Cheng | Conditions: IBI363 + Chemotherapy | Phase 1 | Status: RECRUITING